Eli Lilly and Co. and Health Care Businesses and Health Care & Life Sciences

Eli Lilly invests in $250M Australian venture fund

May 20, 2010

The Australian state of Queensland and Indianapolis-based Eli Lilly and Co. have created a $250 million venture capital fund to expand and develop the biotechnology industry, Queensland Premier Anna Bligh said in a statement.

Lilly has pledged up to 20 percent of the fund, while the Queensland government has contributed $25 million. Other unnamed strategic U.S. investors have also agreed to participate, according to a Queensland government press release.

The unnamed venture fund will be based in Brisbane, and will focus on biotechnology investments in Australia and southeastern Asia.

Lilly has had a presence in Australia for 50 years. It has several partnership deals in the state of Queensland and has invested in one start-up there: St. Lucia-based Protagonist Pty., in 2006. Lilly spokesman Mark Taylor said that by investing in the fund, the company will formalize and deepen its relationship to the region.

ADVERTISEMENT

Recent Articles by IBJ Staff and Bloomberg News

Comments powered by Disqus